Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes

Atherosclerosis

Volumn 181, Issue 2, 2005, Pages 339-344

  Fukui, Michiaki ^a   Kitagawa, Yoshihiro ^a   Nakamura, Naoto ^b   Kadono, Mayuko ^a   Yoshida, Makie ^a   Hirata, Chizuko ^a   Wada, Katsuya ^a   Hasegawa, Goji ^b   Yoshikawa, Toshikazu ^b  

^a WEST JAPAN RAILWAY COMPANY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carotid atherosclerosis; Dehydroepiandrosterone; Men; Type 2 diabetes

Indexed keywords

PRASTERONE SULFATE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DEHYDROEPIANDROSTERONE SULFATE; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 22544474699     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.014     Document Type: Article

References (32)

1. J. Slowinska-Srzednicka, S. Zgliczynski, and M. Ciswicka-Sznajderman Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction Atherosclerosis 79 1989 197 203
2. A.E. Hak, J.C. Witteman, and F.H. de Jong Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study J Clin Endocrinol Metab 87 2002 3632 3639
3. D.M. Herrington, G.B. Gordon, and S.C. Achuff Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography J Am Coll Cardiol 16 1990 862 870
4. D.M. Eich, J.E. Nestler, and D.E. Johnson Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation Circulation 87 1993 261 269
5. G.B. Gordon, D.E. Bush, and H.F. Weisman Reduction of atherosclerosis by administration of dehydroepiandrosterone A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury J Clin Invest 82 1988 712 720
6. 4 in relation to ischemic heart disease mortality in diabetic subjects The Wisconsin Epidemiologic Study of Diabetic Retinopathy Diabetes Care 19 1996 1045 1050
7. S. Kiechl, J. Willeit, and E. Bonora No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck study) Arterioscler Thromb Vasc Biol 20 2000 1094 1100
8. H. Kawano, H. Yasue, and A. Kitagawa Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men J Clin Endocrinol Metab 88 2003 3190 3195
9. M. Fukui, M. Koyama, and Y. Nakagawa Castration and diabetes Diabets Care 23 2000 1032 1033
10. A. Holmang, and P. Bjorntorp The effects of testosterone on insulin sensitivity in male rats Acta Physiol Scand 146 1992 505 510
11. S.M. Haffner, R.A. Valdez, and L. Mykkanen Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men Metabolism 43 1994 599 603
12. M. Fukui, Y. Kitagawa, and N. Nakamura Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes Diabetes Care 26 2003 1869 1873
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 25 2002 S5 S20
14. M. Fukui, Y. Kitagawa, and N. Nakamura Hepatitis C virus and atherosclerosis in patients with type 2 diabetes J Am Med Assoc 289 2003 1245 1246
15. N. Handa, M. Matsumoto, and H. Maeda Ultrasonic evaluation of early carotid atherosclerosis Stroke 21 1990 1567 1572
16. F. Labrie, A. Belanger, and L. Cusan Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging J Clin Endocrinol Metab 82 1997 2396 2402
17. S.M. Haffner, R.A. Valdez, and M.P. Stern Obesity, body fat distribution and sex hormones in men Int J Obes Relat Metab Disord 17 1993 643 649
18. M. Kimura, S. Tanaka, and Y. Yamada Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats Endocrinology 139 1998 3249 3253
19. J.E. Nestler, J.N. Clore, and W.G. Blackard Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis? FASEB J 6 1992 3073 3075
20. J.E. Nestler, M.A. McClanahan, and J.N. Clore Insulin inhibits adrenal 17,20-lyase activity in man J Clin Endocrinol Metab 74 1992 362 367
21. M.R.I. Williams, S. Ling, and T. Dawood Dehydroepiandrosterone inhibits vascular smooth muscle cell proliferation independent of ARs and ERs J Clin Endocrinol Metab 87 2002 176 181
22. D. Furutama, R. Fukui, and M. Amakawa Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate Biochim Biophys Acta 1406 1998 107 114
23. A. Yoneyama, Y. Kamiya, and M. Kawaguchi Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells Life Sci 60 1997 833 838
24. K. Okamoto Relationship between dehydroepiandrosterone sulfate and serum lipid levels in Japanese men J Epidemiol 6 1996 63 67
25. R.L. Jesse, K. Loesser, and D.M. Eich Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo Ann N Y Acad Sci 774 1995 281 290
26. M. Barbagallo, J. Shan, and P.K. Pang Effects of dehydroepiandrosterone sulfate on cellular calcium responsiveness and vascular contractility Hypertension 26 1995 1065 1069
27. R.H. Straub, L. Konecna, and S. Hrach Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence J Clin Endocrinol Metab 83 1998 2012 2017
28. S.W.J. Lamberts, A.W. van den Beld, and A.J. van der Lely The endocrinology of aging Science 278 1997 419 424
29. E. Barrett-Connor Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus Ann Intern Med 117 1992 807 811
30. H. Ueshiba, Y. Shimizu, and N. Hiroi Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus Eur J Endocrinol 146 2002 375 380
31. S.F. Dinneen, and H.C. Gerstein The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature Arch Intern Med 157 1997 1413 1418
32. C.D.A. Stehouwer, M.A. Gall, and J.W.R. Twisk Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes Diabetes 51 2002 1157 1165